YAP1 and central nervous system cancer: To further explore whether the Hippo pathway could influence epithelial-mesenchymal transition (EMT) in glioma cell lines, we first designed siRNA to respectively downregulate the expression of YAP1 and TEAD2, two important downstream factors of the Hippo pathway.